146 related articles for article (PubMed ID: 15386727)
1. Exposure misclassification as a result of free sample drug utilization in automated claims databases and its effect on a pharmacoepidemiology study of selective COX-2 inhibitors.
Jacobus S; Schneeweiss S; Chan KA
Pharmacoepidemiol Drug Saf; 2004 Oct; 13(10):695-702. PubMed ID: 15386727
[TBL] [Abstract][Full Text] [Related]
2. Withdrawal of COX-2 selective inhibitors rofecoxib and valdecoxib: impact on NSAID and gastroprotective drug prescribing and utilization.
Sun SX; Lee KY; Bertram CT; Goldstein JL
Curr Med Res Opin; 2007 Aug; 23(8):1859-66. PubMed ID: 17605893
[TBL] [Abstract][Full Text] [Related]
3. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
4. Supplementary data collection with case-cohort analysis to address potential confounding in a cohort study of thromboembolism in oral contraceptive initiators matched on claims-based propensity scores.
Eng PM; Seeger JD; Loughlin J; Clifford CR; Mentor S; Walker AM
Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):297-305. PubMed ID: 18215000
[TBL] [Abstract][Full Text] [Related]
5. Comparison of health insurance claims and patient interviews in assessing drug use: data from the Three-City (3C) Study.
Noize P; Bazin F; Dufouil C; Lechevallier-Michel N; Ancelin ML; Dartigues JF; Tzourio C; Moore N; Fourrier-Réglat A
Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):310-9. PubMed ID: 19241438
[TBL] [Abstract][Full Text] [Related]
6. Potential bias in pharmacoepidemiological studies due to the length of the drug free period: a study on antidepressant drug use in adults in the Netherlands.
Gardarsdottir H; Heerdink ER; Egberts AC
Pharmacoepidemiol Drug Saf; 2006 May; 15(5):338-43. PubMed ID: 16496430
[TBL] [Abstract][Full Text] [Related]
7. Proper interpretation of non-differential misclassification effects: expectations vs observations.
Jurek AM; Greenland S; Maldonado G; Church TR
Int J Epidemiol; 2005 Jun; 34(3):680-7. PubMed ID: 15802377
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs and risk of stroke.
Haag MD; Bos MJ; Hofman A; Koudstaal PJ; Breteler MM; Stricker BH
Arch Intern Med; 2008 Jun; 168(11):1219-24. PubMed ID: 18541831
[TBL] [Abstract][Full Text] [Related]
9. Immortal time bias in pharmaco-epidemiology.
Suissa S
Am J Epidemiol; 2008 Feb; 167(4):492-9. PubMed ID: 18056625
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, incidence and persistence of antipsychotic drug prescribing in the Italian general population: retrospective database analysis, 1999-2002.
Mirandola M; Andretta M; Corbari L; Sorio A; Nosè M; Barbui C
Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):412-20. PubMed ID: 16287199
[TBL] [Abstract][Full Text] [Related]
11. Use of prescription drug samples in the US and implications for pharmacoepidemiologic research: a systematic search of the literature.
Acton EK; Hennessy S
Expert Rev Pharmacoecon Outcomes Res; 2021 Aug; 21(4):541-551. PubMed ID: 33730962
[TBL] [Abstract][Full Text] [Related]
12. Drug exposure risk windows and unexposed comparator groups for cohort studies in pharmacoepidemiology.
McMahon AD; Evans JM; McGilchrist MM; McDevitt DG; MacDonald TM
Pharmacoepidemiol Drug Saf; 1998 Jul; 7(4):275-80. PubMed ID: 15073990
[TBL] [Abstract][Full Text] [Related]
13. Exposure-dependent misclassification of exposure in interaction analyses.
Lundberg M; Hallqvist J; Diderichsen F
Epidemiology; 1999 Sep; 10(5):545-9. PubMed ID: 10468429
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics.
Schneeweiss S
Pharmacoepidemiol Drug Saf; 2006 May; 15(5):291-303. PubMed ID: 16447304
[TBL] [Abstract][Full Text] [Related]
15. Association between nonnaproxen NSAIDs, COX-2 inhibitors and hospitalization for acute myocardial infarction among the elderly: a retrospective cohort study.
Rahme E; Watson DJ; Kong SX; Toubouti Y; LeLorier J
Pharmacoepidemiol Drug Saf; 2007 May; 16(5):493-503. PubMed ID: 17086567
[TBL] [Abstract][Full Text] [Related]
16. Outcome misclassification: Impact, usual practice in pharmacoepidemiology database studies and an online aid to correct biased estimates of risk ratio or cumulative incidence.
Hall GC; Lanes S; Bollaerts K; Zhou X; Ferreira G; Gini R
Pharmacoepidemiol Drug Saf; 2020 Nov; 29(11):1450-1455. PubMed ID: 32860317
[TBL] [Abstract][Full Text] [Related]
17. Misclassification of exposure is high when interview data on drug use are used as a proxy measure of chronic drug use during follow-up.
Beiderbeck AB; Sturkenboom MC; Coebergh JW; Leufkens HG; Stricker BH
J Clin Epidemiol; 2004 Sep; 57(9):973-7. PubMed ID: 15504640
[TBL] [Abstract][Full Text] [Related]
18. An application of propensity score matching using claims data.
Seeger JD; Williams PL; Walker AM
Pharmacoepidemiol Drug Saf; 2005 Jul; 14(7):465-76. PubMed ID: 15651087
[TBL] [Abstract][Full Text] [Related]
19. Estimating the effect of current, previous and never use of drugs in studies based on prescription registries.
Nielsen LH; Løkkegaard E; Andreasen AH; Hundrup YA; Keiding N
Pharmacoepidemiol Drug Saf; 2009 Feb; 18(2):147-53. PubMed ID: 19072775
[TBL] [Abstract][Full Text] [Related]
20. Effects of a prior-authorization policy for celecoxib on medical service and prescription drug use in a managed care Medicaid population.
Hartung DM; Touchette DR; Ketchum KL; Haxby DG; Goldberg BW
Clin Ther; 2004 Sep; 26(9):1518-32. PubMed ID: 15531015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
